Capreomycin

Capreomycin

File:Capreomycin IA.svg
File:Capreomycin IB.svg
Clinical data
ATC code	J04AB30 (WHO)
Identifiers
CAS Number	11003-38-6
PubChem CID	3032400
DrugBank	APRD00844
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C25H44N14O8
Molar mass	668.706 g/mol

WikiDoc Resources for Capreomycin
Articles
Most recent articles on Capreomycin Most cited articles on Capreomycin Review articles on Capreomycin Articles on Capreomycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Capreomycin Images of Capreomycin Photos of Capreomycin Podcasts & MP3s on Capreomycin Videos on Capreomycin
Evidence Based Medicine
Cochrane Collaboration on Capreomycin Bandolier on Capreomycin TRIP on Capreomycin
Clinical Trials
Ongoing Trials on Capreomycin at Clinical Trials.gov Trial results on Capreomycin Clinical Trials on Capreomycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Capreomycin NICE Guidance on Capreomycin NHS PRODIGY Guidance FDA on Capreomycin CDC on Capreomycin
Books
Books on Capreomycin
News
Capreomycin in the news Be alerted to news on Capreomycin News trends on Capreomycin
Commentary
Blogs on Capreomycin
Definitions
Definitions of Capreomycin
Patient Resources / Community
Patient resources on Capreomycin Discussion groups on Capreomycin Patient Handouts on Capreomycin Directions to Hospitals Treating Capreomycin Risk calculators and risk factors for Capreomycin
Healthcare Provider Resources
Symptoms of Capreomycin Causes & Risk Factors for Capreomycin Diagnostic studies for Capreomycin Treatment of Capreomycin
Continuing Medical Education (CME)
CME Programs on Capreomycin
International
Capreomycin en Espanol Capreomycin en Francais
Business
Capreomycin in the Marketplace Patents on Capreomycin
Experimental / Informatics
List of terms related to Capreomycin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Capreomycin is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.

The drug should not be given with streptomycin or other drugs that may damage the 8th nerve.